2nd Biosimilars Congregation 2013

Top Quote "Uniting industry leaders to analyse advanced commercial developments & to identify successful management strategies of Biosimilars". End Quote
  • (1888PressRelease) December 01, 2012 - Key Themes Discussed at this Conference:

    Exploiting the latest technologies, methodologies and introducing pharmacy automations on work practices of Pharmacovigilance in EU, US and Asia
    Impact of the new European Pharmacovigilance legislation - Implementation and Beyond
    Keeping abreast of the changes impacting the drug safety industry to ensure the pharmacovigilance strategies are robust and geared to compliance
    Recent successful strategies and business models to bring out new medicines
    How will PV activities change with Clinical Trial Transformation Initiative?
    Discover approaches for collecting, integrating and analyzing all of the safety data generated from preclinical models
    Identifying essential antidote requirements and learn to implement best practices in drug safety and surveillance
    Exploiting the pharmacy automations and technologies for enhancement of medication safety
    Impact of technology - learn and explore
    Latest developments in pharmacovigilance, drug safety and risk management to ensure safer drugs to market
    Improving patient care and safety in relation to use of medicines and all medical and paramedical interventions
    Determining the steps and strategies for enhancing quality in healthcare
    Improving patient care and safety in relation to use of medicines and all medical and paramedical interventions
    Review the use of Periodic Safety Update Reports (PSURs) post-authorisation for safety signals
    Dwell ahead of regulatory developments & improving your risk management strategies in a cost effective way in EU, US and Asia
    Updating yourself with respect to terms of legislation, policies, systems, technology, communication strategies and best practice in PV
    Accelerating new medicine introduction in developing world & overcoming challenges
    Explaining how to use the data sources and observational research for effective safety analysis
    Good supply chain management practices for medicine distribution
    Be part of a major networking opportunity.
    Key Speakers Include:
    Julia Appelskog, Pharmacovigilance Country Lead, Merck
    William Gregory, Director, Safety & Risk Management, Pfizer
    Christina Strom Moller, VP Patient Safety Late Development & Marketed Products, Europe, AstraZeneca (TBC)
    John Parkinson, Director CPRD, MHRA
    Mustafa A. Zaman, Senior Consultant - Integrated Product Development (IPD), Parexel
    Astrid Herpers, Regional PV Director Western Europe, Boehringer Ingelheim
    Sumit Munjal, Oncology Physician & EU Region Medical Advisor -Pharmacovigilance Millennium, Takeda Oncology Company
    Ashok Srivastava, Medical Oncologist/ Hematologist, CMO & Chief Safety Officer Owner & President, Global PharmaTek (USA)
    Pipasha Biswas, Chairperson, Drug Safety & Pharmacoigilance Committee, Director & QPPV Pharmacovigilance & Pharmacoepidemiology, Symogen
    Shelley Gandhi, Director - Pharmacovigilance & Drug Safety, NDA Regulatory Services
    Saad Shakir, Director, Drug Safety Research Unit
    John Whitebrook, Director, Deloitte Consulting
    Plus Many More...

    Who Should Attend:

    VPs, Directors, Heads, Managers, Scientific Advisors, Consultants of:-
    Pharmacovigilance
    Pharmacoepidemiology
    Pharmacogenomics
    Drug/Product Safety
    Drug Development
    Information and Clinical Data Management
    Clinical Pharmacology
    Clinical Safety
    Periodical safety update reports
    Risk Management
    Research & Development
    Quality Assurance
    Patient Safety
    Signal Detection
    Safety Surveillance
    Outcomes Research
    Data Analysis
    Epidemiology
    Medical Affairs
    Regulatory Affairs and Compliance
    Information technology
    Sales and Marketing

    Why Should You Attend:
    4th Pharmacovigilance 2013- "Uniting "Ensuring safer drugs to market by analyzing latest developments in pharmacovigilance, drug safety and risk management"

    Get more from the event, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking drinks time, meet the leading international vendors showcasing the products of tomorrow in the co-located exhibition. Expand your knowledge of the latest business models and strategies in the high-level conference. Whether you are on the branded or generic side, you cannot afford to miss this opportunity to benchmark your tactics and strategies against the industry leaders who will be the first to traverse the pathway. Devise an immediate action plan for your biosimilar prosecution and litigation strategies in light of the barriers to entry, research and development costs, and regulatory hurdles, which are balanced against an enormous potential for increased profit margins.

    Conference Booking Details:-

    Super Early Discount (Till 12th January 2013):- Conference Delegate Pass ( 500 + VAT per delegate) - You can simply email or call and book your conference delegate seats on TEL (UK): + 44 20 3302 4659. TEL (India): + 91 44 4213 8101. Email - tania @ virtueinsightuk . com

    Early Discount (13th January 2013- 12th February 2013):- Conference Delegate Pass ( 700 + VAT per delegate) - You can simply email or call and book your conference delegate seats on TEL (UK): + 44 20 3302 4659. TEL (India): + 91 44 4213 8101. Email - tania @ virtueinsightuk . com

    Standard Registration (After 20th January 2013):- Conference Delegate Pass ( 900 + VAT per delegate) - You can simply email or call and book your conference delegate seats on TEL (UK): + 44 20 3302 4659. TEL (India): + 91 44 4213 8101. Email - tania @ virtueinsightuk . com

    Conference Sponsor & Exhibition Stall - Should you wish to Sponsor, or purchase a Exhibiton Stall (Booth) or a paid Speaker Slot, you can simply email your interest and queries to - TEL (UK): + 44 20 3302 4659. TEL (India): + 91 44 4213 8101. Email - tania @ virtueinsightuk . com

    For more info on the event and for event brochure kindly visit -
    http://www.virtueinsight.com/pharma/2nd-Biosimilars-Congregation-2013/

    ###
space
space
  • FB Icon Twitter Icon In-Icon
Contact Information